Evidence map›Paper›PMID 35204781›Full record

ArticleBiomolecules2022

Vasorelaxant Activity of AP39, a Mitochondria-Targeted H

Leonardo A da Costa Marques, Simone A Teixeira, Flávia N de Jesus, Mark E Wood, Roberta Torregrossa, Matthew Whiteman, Soraia K P Costa, Marcelo N Muscará

Open access · goldAbstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomolecules, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed, 1 pooled it
1.9field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 1 synthesis or guideline pooled it, 14 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Pills of Multi-Target HInternational journal of molecular sciences · 2024
    Review
  5. Article
  6. Review
  7. Biological Functions of Hydrogen Sulfide in Plants.International journal of molecular sciences · 2022
    Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 3 institutions in 3 countries.

Leonardo A da Costa MarquesDepartment of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-000, SP, Brazil.ORCID 0000-0001-6022-1460
Simone A TeixeiraDepartment of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-000, SP, Brazil.
Flávia N de JesusDepartment of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-000, SP, Brazil.
Mark E WoodMedical School, University of Exeter, Exeter EX1 2LU, UK.
Roberta TorregrossaMedical School, University of Exeter, Exeter EX1 2LU, UK.
Matthew WhitemanMedical School, University of Exeter, Exeter EX1 2LU, UK.
Soraia K P CostaDepartment of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-000, SP, Brazil.ORCID 0000-0002-2574-4490
Marcelo N MuscaráDepartment of Pharmacology, Institute of Biomedical Sciences, University of Sao Paulo, Sao Paulo 05508-000, SP, Brazil.
Universidade de São Paulo · BRUniversity of Exeter · GBUniversity of Calgary · CA

Funding

Medical Research Council MR/S002626/1
6 · The paper itself

Abstract

Mitochondria-targeted hydrogen sulfide (H

Indexed as

Mesenteric ArteriesVasodilator AgentsAnimalsMiceMitochondriaThiones5-(4-hydroxyphenyl)-3H-1,2-dithiole-3-thioneThionesVasodilator Agentshydrogen sulfidemesenteric arterymitochondriavasorelaxation

Identifiers

PMID35204781
PMCPMC8961640
OpenAlexW4211100273

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.